Page 297
House Bill No. 5506
Public Act No. 22-118 297 of 739
the schedule designated by the Drug Enforcement Administration or successor agency for MDMA, as defined in section 200 of this act, and psilocybin, as defined in said section, if MDMA and psilocybin have been approved by said administration, or successor agency, to have a medical use and are reclassified in any schedule of controlled substances or unscheduled by said administration or successor agency. [(f)] (g) A new or amended regulation under this chapter shall be adopted in accordance with the provisions of chapter 54. [(g)] (h) In the event of any inconsistency between the contents of schedules I, II, III, IV and V of the controlled substance scheduling regulations and schedules I, II, III, IV and V of the federal Controlled Substances Act, as amended, the provisions of the federal act shall prevail, except (1) when the provisions of the Connecticut controlled substance scheduling regulations place a controlled substance in a schedule with a higher numerical designation, schedule I being the highest designation, or (2) as provided in subsection (e) of this section. [(h)] (i) When a drug that is not a controlled substance in schedule I, II, III, IV or V, as designated in the Connecticut controlled substance scheduling regulations, is designated to be a controlled substance under the federal Controlled Substances Act, such drug shall be considered to be controlled at the state level in the same numerical schedule from the effective date of the federal classification. Nothing in this section shall prevent the Commissioner of Consumer Protection from designating a controlled substance differently in the Connecticut controlled substance scheduling regulations than such controlled substance is designated in the federal Controlled Substances Act, as amended from time to time. [(i)] (j) The Commissioner of Consumer Protection shall, by regulation adopted pursuant to this section, designate the following substances, by whatever official, common, usual, chemical or trade name designation, as controlled substances and classify each such